{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T17:28:06Z","timestamp":1773422886592,"version":"3.50.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,11,23]]},"DOI":"10.7759\/cureus.49320","type":"journal-article","created":{"date-parts":[[2023,11,24]],"date-time":"2023-11-24T07:56:11Z","timestamp":1700812571000},"source":"Crossref","is-referenced-by-count":2,"title":["Effectiveness of the Combination of Probiotic Supplementation on Motor Symptoms and Constipation in Parkinson\u2019s Disease"],"prefix":"10.7759","author":[{"given":"Athanasia","family":"Alexoudi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lydia","family":"Kesidou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stylianos","family":"Gatzonis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christos","family":"Charalampopoulos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Areti","family":"Tsoga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2017.0603","article-title":"Survival and causes of death among people with clinically diagnosed synucleinopathies with parkinsonism: a population-based study","volume":"74","author":"Savica R","year":"2017","unstructured":"Savica R, Grossardt B, Bower J, et al.. Survival and causes of death among people with clinically diagnosed synucleinopathies with parkinsonism: a population-based study. JAMA Neurol. 2017, 74:839-46. 10.1001\/jamaneurol.2017.0603","journal-title":"JAMA Neurol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2018.00125","article-title":"The exosomal\/total \u03b1-synuclein ratio in plasma is associated with glucocerebrosidase activity and correlates with measures of disease severity in PD patients","volume":"12","author":"Cerri S","year":"2018","unstructured":"Cerri S, Ghezzi C, Sampieri M, et al.. The exosomal\/total \u03b1-synuclein ratio in plasma is associated with glucocerebrosidase activity and correlates with measures of disease severity in PD patients. Front Cell Neurosci. 2018, 12:125. 10.3389\/fncel.2018.00125","journal-title":"Front Cell Neurosci"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1002\/mds.26424","article-title":"MDS clinical diagnostic criteria for Parkinson's disease","volume":"30","author":"Postuma RB","year":"2015","unstructured":"Postuma RB, Berg D, Stern M, et al.. MDS clinical diagnostic criteria for Parkinson's disease. Mov Disord. 2015, 30:1591-601. 10.1002\/mds.26424","journal-title":"Mov Disord"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1038\/nrn.2017.62","article-title":"Non-motor features of Parkinson disease","volume":"18","author":"Schapira A","year":"2017","unstructured":"Schapira A, Chaudhuri K, Jenner P. Non-motor features of Parkinson disease. Nat Rev Neurosci. 2017, 18:435-50. 10.1038\/nrn.2017.62","journal-title":"Nat Rev Neurosci"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2014.3654","article-title":"Pharmacological treatment of Parkinson disease: a review","volume":"311","author":"Connolly B","year":"2014","unstructured":"Connolly B, Lang A. Pharmacological treatment of Parkinson disease: a review. JAMA. 2014, 311:1670-83. 10.1001\/jama.2014.3654","journal-title":"JAMA"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1002\/mds.28075","article-title":"Ten unsolved questions about neuroinflammation in Parkinson's disease","volume":"36","author":"Hirsch EC","year":"2021","unstructured":"Hirsch EC, Standaert DG. Ten unsolved questions about neuroinflammation in Parkinson's disease. Mov Disord. 2021, 36:16-24. 10.1002\/mds.28075","journal-title":"Mov Disord"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1186\/s40035-019-0172-x","article-title":"Beyond the synucleinopathies: alpha synuclein as a driving force in neurodegenerative comorbidities","volume":"8","author":"Visanji N","year":"2019","unstructured":"Visanji N, Lang A, Kovacs G. Beyond the synucleinopathies: alpha synuclein as a driving force in neurodegenerative comorbidities. Transl Neurodegener. 2019, 8:28. 10.1186\/s40035-019-0172-x","journal-title":"Transl Neurodegener"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2019.00574","article-title":"The gut and Parkinson's disease-a bidirectional pathway","volume":"10","author":"Santos S","year":"2019","unstructured":"Santos S, de Oliveira H, Yamada E, Neves B, Pereira A, Jr. The gut and Parkinson's disease-a bidirectional pathway. Front Neurol. 2019, 10:574. 10.3389\/fneur.2019.00574","journal-title":"Front Neurol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4939-0897-4_17","article-title":"The impact of microbiota on brain and behavior: mechanisms & therapeutic potential","volume":"817","author":"Borre Y","year":"2014","unstructured":"Borre Y, Moloney R, Clarke G, Dinan T, Cryan J. The impact of microbiota on brain and behavior: mechanisms & therapeutic potential. Adv Exp Med Biol. 2014, 817:373-403. 10.1007\/978-1-4939-0897-4_17","journal-title":"Adv Exp Med Biol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuint.2018.08.005","article-title":"Unhealthy gut, unhealthy brain: the role of the intestinal microbiota in neurodegenerative diseases","volume":"120","author":"Spielman LJ","year":"2018","unstructured":"Spielman LJ, Gibson DL, Klegeris A. Unhealthy gut, unhealthy brain: the role of the intestinal microbiota in neurodegenerative diseases. Neurochem Int. 2018, 120:149-63. 10.1016\/j.neuint.2018.08.005","journal-title":"Neurochem Int"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2023.e14312","article-title":"Evaluating the effectiveness of probiotics in relieving constipation in Parkinson's disease: A systematic review and meta-analysis","volume":"9","author":"Ghalandari N","year":"2023","unstructured":"Ghalandari N, Assarzadegan F, Mahdavi H, Jamshidi E, Esmaily H. Evaluating the effectiveness of probiotics in relieving constipation in Parkinson's disease: A systematic review and meta-analysis. Heliyon. 2023, 9:10.1016\/j.heliyon.2023.e14312","journal-title":"Heliyon"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jnutbio.2018.03.009","article-title":"Short-chain fatty acids suppress food intake by activating vagal afferent neurons","volume":"57","author":"Goswami C","year":"2018","unstructured":"Goswami C, Iwasaki Y, Yada T. Short-chain fatty acids suppress food intake by activating vagal afferent neurons. J Nutr Biochem. 2018, 57:130-5. 10.1016\/j.jnutbio.2018.03.009","journal-title":"J Nutr Biochem"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.02179-19","article-title":"New view on dietary fiber selection for predictable shifts in gut microbiota","volume":"11","author":"Cantu-Jungles T","year":"2020","unstructured":"Cantu-Jungles T, Hamaker B. New view on dietary fiber selection for predictable shifts in gut microbiota. mBio. 2020, 11:10.1128\/mBio.02179-19","journal-title":"mBio"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.neulet.2016.02.009","article-title":"Butyrate, neuroepigenetics and the gut microbiome: can a high fiber diet improve brain health?","volume":"625","author":"Bourassa M","year":"2016","unstructured":"Bourassa M, Alim I, Bultman S, Ratan R. Butyrate, neuroepigenetics and the gut microbiome: can a high fiber diet improve brain health?. Neurosci Lett. 2016, 625:56-63. 10.1016\/j.neulet.2016.02.009","journal-title":"Neurosci Lett"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.exger.2021.111376","article-title":"Neuroprotective effects of short-chain fatty acids in MPTP induced mice model of Parkinson's disease","volume":"150","author":"Hou Y","year":"2021","unstructured":"Hou Y, Li X, Liu C, et al.. Neuroprotective effects of short-chain fatty acids in MPTP induced mice model of Parkinson's disease. Exp Gerontol. 2021, 150:10.1016\/j.exger.2021.111376","journal-title":"Exp Gerontol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1007\/s11418-017-1150-1","article-title":"Effects of saffron and its constituents, crocin-1, crocin-2, and crocetin on \u03b1-synuclein fibrils","volume":"72","author":"Inoue E","year":"2018","unstructured":"Inoue E, Shimizu Y, Masui R, et al.. Effects of saffron and its constituents, crocin-1, crocin-2, and crocetin on \u03b1-synuclein fibrils. J Nat Med. 2018, 72:274-9. 10.1007\/s11418-017-1150-1","journal-title":"J Nat Med"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.febslet.2004.09.038","article-title":"Mutation E46K increases phospholipid binding and assembly into filaments of human alpha-synuclein","volume":"576","author":"Choi W","year":"2004","unstructured":"Choi W, Zibaee S, Jakes R, et al.. Mutation E46K increases phospholipid binding and assembly into filaments of human alpha-synuclein. FEBS Lett. 2004, 576:363-8. 10.1016\/j.febslet.2004.09.038","journal-title":"FEBS Lett"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1021\/acschemneuro.1c00379","article-title":"Crocin inhibits the fibrillation of human \u03b1-synuclein and disassembles mature fibrils: experimental findings and mechanistic insights from molecular dynamics simulation","volume":"12","author":"Saffari B","year":"2021","unstructured":"Saffari B, Amininasab M. Crocin inhibits the fibrillation of human \u03b1-synuclein and disassembles mature fibrils: experimental findings and mechanistic insights from molecular dynamics simulation. ACS Chem Neurosci. 2021, 12:4037-57. 10.1021\/acschemneuro.1c00379","journal-title":"ACS Chem Neurosci"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1186\/1472-6882-4-12","article-title":"Comparison of Crocus sativus L. and imipramine in the treatment of mild to moderate depression: a pilot double-blind randomized trial [ISRCTN45683816]","volume":"4","author":"Akhondzadeh S","year":"2004","unstructured":"Akhondzadeh S, Fallah-Pour H, Afkham K, Jamshidi AH, Khalighi-Cigaroudi F. Comparison of Crocus sativus L. and imipramine in the treatment of mild to moderate depression: a pilot double-blind randomized trial [ISRCTN45683816]. BMC Complement Altern Med. 2004, 4:12. 10.1186\/1472-6882-4-12","journal-title":"BMC Complement Altern Med"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.579052","article-title":"Neuroprotective potency of saffron against neuropsychiatric diseases, neurodegenerative diseases, and other brain disorders: from bench to bedside","volume":"11","author":"Bian Y","year":"2020","unstructured":"Bian Y, Zhao C, Lee S. Neuroprotective potency of saffron against neuropsychiatric diseases, neurodegenerative diseases, and other brain disorders: from bench to bedside. Front Pharmacol. 2020, 11:10.3389\/fphar.2020.579052","journal-title":"Front Pharmacol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19082245","article-title":"Vitamin D in neurological diseases: a rationale for a pathogenic impact","volume":"19","author":"Moretti R","year":"2018","unstructured":"Moretti R, Morelli ME, Caruso P. Vitamin D in neurological diseases: a rationale for a pathogenic impact. Int J Mol Sci. 2018, 19:10.3390\/ijms19082245","journal-title":"Int J Mol Sci"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1002\/jbm4.10419","article-title":"Vitamin D: brain and behavior","volume":"5","author":"Eyles D","year":"2021","unstructured":"Eyles D. Vitamin D: brain and behavior. JBMR Plus. 2021, 5:10.1002\/jbm4.10419","journal-title":"JBMR Plus"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1111\/jnc.13971","article-title":"Calcipotriol inhibits \u03b1-synuclein aggregation in SH-SY5Y neuroblastoma cells by a Calbindin-D28k-dependent mechanism","volume":"141","author":"Rcom-H'cheo-Gauthier A","year":"2017","unstructured":"Rcom-H'cheo-Gauthier A, Meedeniya A, Pountney D. Calcipotriol inhibits \u03b1-synuclein aggregation in SH-SY5Y neuroblastoma cells by a Calbindin-D28k-dependent mechanism. J Neurochem. 2017, 141:263-74. 10.1111\/jnc.13971","journal-title":"J Neurochem"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.12659\/msm.912840","article-title":"The association between vitamin d status, Vitamin d supplementation, sunlight exposure, and parkinson's disease: a systematic review and meta-analysis","volume":"25","author":"Zhou Z","year":"2019","unstructured":"Zhou Z, Zhou R, Zhang Z, Li K. The association between vitamin d status, Vitamin d supplementation, sunlight exposure, and parkinson's disease: a systematic review and meta-analysis. Med Sci Monit. 2019, 25:666-74. 10.12659\/msm.912840","journal-title":"Med Sci Monit"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1002\/mds.23429","article-title":"Systematic review of levodopa dose equivalency reporting in Parkinson's disease","volume":"25","author":"Tomlinson CL","year":"2010","unstructured":"Tomlinson CL, Stowe R, Patel S, Rick C, Gray R, Clarke CE. Systematic review of levodopa dose equivalency reporting in Parkinson's disease. Mov Disord. 2010, 25:2649-53. 10.1002\/mds.23429","journal-title":"Mov Disord"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2017.08.3235","article-title":"Sodium butyrate exerts protective effect against Parkinson's disease in mice via stimulation of glucagon like peptide-1","volume":"381","author":"Liu J","year":"2017","unstructured":"Liu J, Wang F, Liu S, et al.. Sodium butyrate exerts protective effect against Parkinson's disease in mice via stimulation of glucagon like peptide-1. J Neurol Sci. 2017, 381:176-81. 10.1016\/j.jns.2017.08.3235","journal-title":"J Neurol Sci"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddx114","article-title":"Sodium butyrate rescues dopaminergic cells from alpha-synuclein-induced transcriptional deregulation and DNA damage","volume":"26","author":"Paiva I","year":"2017","unstructured":"Paiva I, Pinho R, Pavlou MA, et al.. Sodium butyrate rescues dopaminergic cells from alpha-synuclein-induced transcriptional deregulation and DNA damage. Hum Mol Genet. 2017, 26:2231-46. 10.1093\/hmg\/ddx114","journal-title":"Hum Mol Genet"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuro.2015.12.010","article-title":"Evidence of neuroprotective effects of saffron and crocin in a Drosophila model of parkinsonism","volume":"52","author":"Rao S","year":"2016","unstructured":"Rao S, Muralidhara, Yenisetti S, Rajini P. Evidence of neuroprotective effects of saffron and crocin in a Drosophila model of parkinsonism. Neurotoxicology. 2016, 52:230-42. 10.1016\/j.neuro.2015.12.010","journal-title":"Neurotoxicology"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.4081\/ni.2018.7737","article-title":"Treatment of levodopainduced dyskinesia with Vitamin d: a randomized, double-blind, placebo-controlled trial","volume":"10","author":"Habibi AH","year":"2018","unstructured":"Habibi AH, Anamoradi A, Shahidi GA, Razmeh S, Alizadeh E, Kokhedan KM. Treatment of levodopainduced dyskinesia with Vitamin d: a randomized, double-blind, placebo-controlled trial. Neurol Int. 2018, 10:7737. 10.4081\/ni.2018.7737","journal-title":"Neurol Int"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-45348-z","article-title":"Propionic acid induces gliosis and neuro-inflammation through modulation of PTEN\/AKT pathway in autism spectrum disorder","volume":"9","author":"Abdelli LS","year":"2019","unstructured":"Abdelli LS, Samsam A, Naser SA. Propionic acid induces gliosis and neuro-inflammation through modulation of PTEN\/AKT pathway in autism spectrum disorder. Sci Rep. 2019, 9:8824. 10.1038\/s41598-019-45348-z","journal-title":"Sci Rep"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/201255-effectiveness-of-the-combination-of-probiotic-supplementation-on-motor-symptoms-and-constipation-in-parkinsons-disease","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:10:37Z","timestamp":1707509437000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/201255-effectiveness-of-the-combination-of-probiotic-supplementation-on-motor-symptoms-and-constipation-in-parkinsons-disease"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,23]]},"references-count":30,"URL":"https:\/\/doi.org\/10.7759\/cureus.49320","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11,23]]}}}